CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 42 other locations
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Phase 3
Blue Ash, Ohio, United States and 30 other locations
Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic...
Phase 4
Cincinnati, Ohio, United States and 4 other locations
Multi-Center, Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic...
Phase 2
Blue Ash, Ohio, United States
it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...
Phase 1
Cincinnati, Ohio, United States and 10 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 119 other locations
This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...
Phase 4
Cincinnati, Ohio, United States and 39 other locations
This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weigh...
Phase 2
Cincinnati, Ohio, United States and 92 other locations
of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes...
Phase 2
Cincinnati, Ohio, United States of America and 50 other locations
The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes...
Phase 2
Dayton, Ohio, United States and 55 other locations
Clinical trials
Research sites
Resources
Legal